Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Glaxosmithkline (GSK) Share Price

Price 1,625.00p on 17-10-2025 at 18:50:06
Change -9.00p -0.55%
Buy 1,620.50p
Sell 1,620.00p
Last Trade: Unknown 1,286.00 at 1,625.00p
Day's Volume: 7,130,901
Last Close: 1,625.00p
Open: 1,610.50p
ISIN: GB00BN7SWP63
Day's Range 1,597.00p - 1,625.00p
52wk Range: 1,242.50p - 1,684.50p
Market Capitalisation: £65.34b
VWAP: 1,614.39757p
Shares in Issue: 4.02b

Glaxosmithkline (GSK) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Unknown* 1,286 1,625.00p OTC Trade
16:38:58 - 17-Oct-25
Unknown* 4,562 1,625.00p OTC Trade
16:38:58 - 17-Oct-25
Unknown* 6,383 1,625.00p OTC Trade
16:38:58 - 17-Oct-25
Unknown* 208 1,625.00p OTC Trade
16:38:58 - 17-Oct-25
Buy* 343 1,625.00p SI Trade
16:35:26 - 17-Oct-25
Buy* 315 1,625.00p SI Trade
16:35:26 - 17-Oct-25
Buy* 242 1,625.00p SI Trade
16:35:26 - 17-Oct-25
Buy* 137 1,625.00p SI Trade
16:35:26 - 17-Oct-25
Buy* 17 1,625.00p SI Trade
16:35:26 - 17-Oct-25
Buy* 20 1,625.00p SI Trade
16:35:26 - 17-Oct-25
See more Glaxosmithkline trades

Glaxosmithkline (GSK) Share Price History

Time period:
to
Date Open High Low Close Volume
17th Oct 2025 (Fri) 1,610.50 1,625.00 1,597.00 1,625.00 7,130,901
16th Oct 2025 (Thu) 1,635.50 1,638.00 1,621.50 1,634.00 6,296,327
15th Oct 2025 (Wed) 1,630.50 1,634.50 1,608.00 1,628.00 6,560,010
14th Oct 2025 (Tue) 1,628.00 1,649.50 1,624.00 1,637.50 4,670,216
13th Oct 2025 (Mon) 1,623.50 1,633.50 1,614.50 1,627.50 5,557,801
10th Oct 2025 (Fri) 1,627.00 1,646.50 1,623.00 1,625.00 6,734,900
9th Oct 2025 (Thu) 1,626.00 1,647.50 1,625.50 1,640.00 7,882,230
8th Oct 2025 (Wed) 1,612.00 1,631.50 1,611.50 1,620.50 6,702,536
7th Oct 2025 (Tue) 1,600.00 1,614.50 1,597.50 1,614.50 6,499,915
6th Oct 2025 (Mon) 1,600.00 1,626.00 1,592.50 1,616.00 10,330,221
3rd Oct 2025 (Fri) 1,630.00 1,651.50 1,596.00 1,628.50 23,609,042
2nd Oct 2025 (Thu) 1,675.50 1,684.50 1,637.50 1,647.00 18,481,439
1st Oct 2025 (Wed) 1,600.00 1,672.00 1,591.00 1,671.50 22,095,384
30th Sep 2025 (Tue) 1,528.00 1,592.00 1,521.00 1,574.50 15,238,201
29th Sep 2025 (Mon) 1,525.00 1,544.00 1,495.00 1,518.00 10,795,090
26th Sep 2025 (Fri) 1,460.50 1,495.50 1,455.00 1,486.00 7,059,102
25th Sep 2025 (Thu) 1,479.00 1,496.50 1,470.00 1,470.50 10,049,291
24th Sep 2025 (Wed) 1,497.50 1,497.50 1,477.50 1,485.00 3,728,639
23rd Sep 2025 (Tue) 1,507.00 1,511.00 1,489.50 1,494.00 4,433,683
22nd Sep 2025 (Mon) 1,502.00 1,514.00 1,491.00 1,511.00 3,120,263
See more Glaxosmithkline price history

Glaxosmithkline (GSK) Regulatory News

Date Source Headline
17th Oct 2025 7:00 am RNS Transaction in Own Shares
16th Oct 2025 3:30 pm RNS Director/PDMR Shareholding
16th Oct 2025 7:00 am RNS Transaction in Own Shares
15th Oct 2025 3:30 pm RNS Director/PDMR Shareholding
15th Oct 2025 7:00 am RNS Transaction in Own Shares
14th Oct 2025 7:00 am RNS GSK receives expanded Shingrix approval in China
14th Oct 2025 7:00 am RNS Transaction in Own Shares
13th Oct 2025 3:30 pm RNS Director/PDMR Shareholding
13th Oct 2025 7:00 am RNS Transaction in Own Shares
10th Oct 2025 3:30 pm RNS Director/PDMR Shareholding
See more Glaxosmithkline regulatory news

Glaxosmithkline (GSK) Share News

LONDON BRIEFING: Pearson outlook steady; Smiths sells Interconnect arm

17th Oct 2025 07:51

(Alliance News) - Pearson reaffirms its 2025 outlook as sales accelerated and Smiths Group agrees to sell its Interconnect division for GBP1.3 billion to Molex. Man Group reports higher assets under management at the end of the third quarter. Read More

HIV prevention jab by GSK's ViiV Healthcare to be offered in England

17th Oct 2025 07:04

(Alliance News) - An injection to prevent HIV is set to be approved for use in England and Wales. Read More

GSK shingles vaccine approved for wider age group in China

14th Oct 2025 09:08

(Alliance News) - GSK PLC on Tuesday said the China National Medical Products Administration has approved its Shingrix injection for immunocompromised adults. Read More

Study shows GSK's niraparib can slow prostate cancer growth

7th Oct 2025 10:10

(Alliance News) - Patients with a certain form of aggressive prostate cancer could benefit from a new combination of drugs which slow cancer growth, according to a new study. Read More

LONDON MARKET CLOSE: FTSE 100 ends record breaking week at new high

3rd Oct 2025 17:00

(Alliance News) - Blue chips in London enjoyed another strong day on Friday, hitting a fresh peak, with a pick up in new listings adding to the more optimistic mood. Read More

See more Glaxosmithkline news
FTSE 100 Latest
Value9,354.57
Change-81.52

Login to your account

Forgot Password?

Not Registered